Simulations Plus Inc (NASDAQ:SLP) — Market Cap & Net Worth
Market Cap & Net Worth: Simulations Plus Inc (SLP)
Simulations Plus Inc (NASDAQ:SLP) has a market capitalization of $372.54 Million ($372.54 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #13850 globally and #3325 in its home market, demonstrating a 0.05% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Simulations Plus Inc's stock price $18.43 by its total outstanding shares 20224838 (20.22 Million). Also see total assets of Simulations Plus Inc for a full breakdown of the balance sheet.
Simulations Plus Inc Market Cap History: 2015 to 2026
Simulations Plus Inc's market capitalization history from 2015 to 2026. Data shows growth from $183.95 Million to $372.74 Million (7.14% CAGR). Also see Simulations Plus Inc operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Index Memberships
Simulations Plus Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Composite
IXIC
|
$41.69 Trillion | 0.00% | #1348 of 3165 |
|
S&P Small-Cap 600 Index
SML
|
$1.61 Trillion | 0.04% | #562 of 602 |
Weight: Simulations Plus Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Simulations Plus Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Simulations Plus Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check latest Simulations Plus Inc stock price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
4.66x
Simulations Plus Inc's market cap is 4.66 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $183.15 Million | $18.31 Million | $3.84 Million | 10.00x | 47.66x |
| 2017 | $310.45 Million | $24.14 Million | $5.79 Million | 12.86x | 53.64x |
| 2018 | $388.88 Million | $29.67 Million | $8.93 Million | 13.11x | 43.52x |
| 2019 | $573.41 Million | $33.97 Million | $8.58 Million | 16.88x | 66.81x |
| 2020 | $1.43 Billion | $41.59 Million | $9.33 Million | 34.28x | 152.78x |
| 2021 | $941.94 Million | $46.47 Million | $9.78 Million | 20.27x | 96.29x |
| 2022 | $732.06 Million | $53.91 Million | $12.48 Million | 13.58x | 58.64x |
| 2023 | $901.12 Million | $59.58 Million | $9.96 Million | 15.13x | 90.46x |
| 2024 | $564.07 Million | $70.01 Million | $9.95 Million | 8.06x | 56.67x |
| 2025 | $368.70 Million | $79.18 Million | -$64.72 Million | 4.66x | N/A |
Competitor Companies of SLP by Market Capitalization
Companies near Simulations Plus Inc in the global market cap rankings as of September 18, 2026. Review how tangible is Simulations Plus Inc's equity to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Simulations Plus Inc by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #734 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1907 globally with a market cap of $12.22 Billion USD ( AU$17.27 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2071 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2140 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #734 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $264.90 |
| #1907 | Pro Medicus Ltd | AU:PME | $12.22 Billion | AU$165.31 |
| #2071 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $69.97 |
| #2140 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $58.96 |
Simulations Plus Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Simulations Plus Inc's market cap moved from $183.95 Million to $ 372.74 Million, with a yearly change of 7.14%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $372.74 Million | +1.10% |
| 2025 | $368.70 Million | -34.64% |
| 2024 | $564.07 Million | -37.40% |
| 2023 | $901.12 Million | +23.09% |
| 2022 | $732.06 Million | -22.28% |
| 2021 | $941.94 Million | -33.93% |
| 2020 | $1.43 Billion | +148.64% |
| 2019 | $573.41 Million | +47.45% |
| 2018 | $388.88 Million | +25.26% |
| 2017 | $310.45 Million | +69.51% |
| 2016 | $183.15 Million | -0.44% |
| 2015 | $183.95 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of Simulations Plus Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $372.54 Million USD |
| MoneyControl | $372.54 Million USD |
| MarketWatch | $372.54 Million USD |
| marketcap.company | $372.54 Million USD |
| Reuters | $372.54 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Simulations Plus Inc
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments. The company offers GastroPlus, which predicts absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics in humans… Read more